March 18th 2024
From our March cover feature: Vulnerable populations such as the prison population should have access to Mohs surgery to prevent the increased risk of morbidity and mortality from skin cancer.
Targeted therapy for skin malignancies
January 22nd 2019The past decade has seen significant advances in the understanding of molecular pathogenesis of skin cancer leading to the development of targeted treatments and immunotherapies that have dramatically improved progression free survival and even overall survival in melanoma, basal cell carcinoma (BCC) and even some rarer cutaneous carcinomas.
Off-label uses for fluorouracil cream not always based on strong evidence
November 13th 2018Topical 5‐fluorouracil is FDA-approved to treat actinic keratoses and superficial basal cell carcinoma, but it is commonly used off-label to treat a number of other skin conditions, such as squamous cell carcinoma despite strong evidence.
Mortality high in squamous cell carcinoma in hidradenitis suppurativa
October 15th 2018Squamous cell carcinoma in hidradenitis suppurativa is rare, but mortality is high, according to Mayo Clinic researchers reporting at the American Society for Dermatologic Surgery annual meeting last week in Phoenix.
Skin cancer prevention messaging works (for some)
May 28th 2018Studies have shown that melanoma incidence rates among non-Hispanic whites have been rising in recent years, which is true ― to a degree, according to a research letter published in March in JAMA Dermatology. The rates are indeed rising for those younger than 15 years old and older than 45 years old. However, the analysis highlights a big dip in melanoma cases for those between 15-44 years.